| Mark F BlaxillAffiliation: Boston Consulting Group Country: USA Study fails to establish diagnostic substitution as a factor in increased rate of autismMark F Blaxill Safe Minds, Cambridge, Massachusetts 02138, USA Pharmacotherapy 24:812-3; author reply 813-5. 2004 What's going on? The question of time trends in autismMark F Blaxill SafeMinds, Cranford, NJ, USA Public Health Rep 119:536-51. 2004 Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), the changing prevalence of autism in CaliforniaMark F Blaxill SafeMinds, Cambridge, Massachusetts, USA J Autism Dev Disord 33:223-6; discussion 227-9. 2003 Reduced levels of mercury in first baby haircuts of autistic childrenAmy S Holmes SafeMinds, Cambridge, Massachusetts, USA Int J Toxicol 22:277-85. 2003 Any changes in prevalence of autism must be determinedMark F Blaxill BMJ 324:296. 2002 Concerns continue over mercury and autismMark F Blaxill Am J Prev Med 26:91; reply 91-2. 2004 Thimerosal and autism? A plausible hypothesis that should not be dismissedMark F Blaxill Safe Minds Sensible Action For Ending Mercury Induced Neurological Disorders, 14 Commerce Drive, PH Cranford, New Jersey 07016, USA Med Hypotheses 62:788-94. 2004
| |